Cash Flow from Financial Activities (Quarterly)

Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.

AVANOS MEDICAL, INC. (AVNS) had Cash Flow from Financial Activities of $56.70M for the most recently reported fiscal quarter, ending 2022-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2022-12-31

Income Statement Financials
Revenue	$217.50M
Net Income	$17.60M
Cost of Goods Sold	$99.70M
Gross Profit	$117.80M
Operating Expenses	$190.40M
Operating Income	$27.10M
Non-Operating Income/Expense	$-2.30M
Pre-Tax Income	$24.80M
Normalized Pre-Tax Income	$24.80M
Income after Taxes	$17.60M
Income from Continuous Operations	$17.60M
Consolidated Net Income/Loss	$17.60M
Normalized Income after Taxes	$17.60M
EBIT	$27.10M
EBITDA	$40.50M
Weighted-Average Shares Outstanding (Basic)	46.90M
Weighted-Average Shares Outstanding (Diluted)	47.30M
Earnings per Share (EPS) (Basic)	$0.38
Earnings per Share (EPS) (Diluted)	$0.38
Balance Sheet Financials
Current Assets	$499.80M
Property, Plant, and Equipment	$163.90M
Long-Term Assets	$1.29B
Total Assets	$1.79B
Current Liabilities	$185.80M
Long-Term Debt	$226.30M
Long-Term Liabilities	$309.90M
Total Liabilities	$495.70M
Common Equity	$1.29B
Tangible Shareholders Equity	$220.80M
Shareholders Equity	$1.29B
Common Shares Outstanding	46.53M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$90.90M
Cash Flow from Investing Activities	$-135.40M
Cash Flow from Financial Activities	$56.70M
Beginning Cash	$118.50M
End Cash	$127.70M
Increase/Decrease in Cash	$9.20M
Stock-Based Compensation	$15.90M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.69
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.15
Debt to Equity Ratio	0.18
Gross Margin	54.16%
Operating Margin	12.46%
EBIT Margin	12.46%
EBITDA Margin	--
Pre-Tax Profit Margin	11.40%
Profit Margin	8.09%
Free Cash Flow	$71.60M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.12
Inventory Turnover	0.52
Receiveable Turnover	1.30
Days Sales in Receivables	69.48
Return on Equity	1.36%
Return on Tangible Equity	7.97%
Return on Assets	0.98%
Return on Investments	1.16%
Book Value Per Share	$27.75
Free Cash Flow per Share	$1.51
Operating Cash Flow per Share	$1.92

Data from Zacks Investment Research, Inc.